Literature DB >> 10085056

Characterization of exochelins of the Mycobacterium bovis type strain and BCG substrains.

J Gobin1, D K Wong, B W Gibson, M A Horwitz.   

Abstract

Pathogenic mycobacteria must acquire iron in the host in order to multiply and cause disease. To do so, they release abundant quantities of siderophores called exochelins, which have the capacity to scavenge iron from host iron-binding proteins and deliver it to the mycobacteria. In this study, we have characterized the exochelins of Mycobacterium bovis, the causative agent of bovine and occasionally of human tuberculosis, and the highly attenuated descendant of M. bovis, bacillus Calmette-Guérin (BCG), widely used as a vaccine against human tuberculosis. The M. bovis type strain, five substrains of M. bovis BCG (Copenhagen, Glaxo, Japanese, Pasteur, and Tice), and two strains of virulent Mycobacterium tuberculosis all produce the same set of exochelins, although the relative amounts of individual exochelins may differ. Among these mycobacteria, the total amount of exochelins produced is greatest in M. tuberculosis, intermediate in M. bovis, and smallest in M. bovis BCG.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085056      PMCID: PMC96566          DOI: 10.1128/IAI.67.4.2035-2039.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  A new group of water-soluble iron-binding compounds from Mycobacteria: the exochelins.

Authors:  L P Macham; C Ratledge
Journal:  J Gen Microbiol       Date:  1975-08

2.  BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics.

Authors:  A Lotte; O Wasz-Höckert; N Poisson; N Dumitrescu; M Verron; E Couvet
Journal:  Adv Tuberc Res       Date:  1984

3.  Determination of the structure of exochelin MN, the extracellular siderophore from Mycobacterium neoaurum.

Authors:  G J Sharman; D H Williams; D F Ewing; C Ratledge
Journal:  Chem Biol       Date:  1995-08

4.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Authors:  G A Colditz; T F Brewer; C S Berkey; M E Wilson; E Burdick; H V Fineberg; F Mosteller
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

5.  A nosocomial outbreak of multidrug-resistant Mycobacterium bovis among HIV-infected patients. A case-control study.

Authors:  E Bouvet; E Casalino; G Mendoza-Sassi; S Lariven; E Vallée; M Pernet; S Gottot; F Vachon
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

6.  Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis.

Authors:  D van Soolingen; P E de Haas; J Haagsma; T Eger; P W Hermans; V Ritacco; A Alito; J D van Embden
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

7.  Mycobactins and exochelins of Mycobacterium tuberculosis, M. bovis, M. africanum and other related species.

Authors:  R Barclay; C Ratledge
Journal:  J Gen Microbiol       Date:  1988-03

8.  Isolation, purification and structure of exochelin MS, the extracellular siderophore from Mycobacterium smegmatis.

Authors:  G J Sharman; D H Williams; D F Ewing; C Ratledge
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

Review 9.  Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen.

Authors:  W M Dankner; N J Waecker; M A Essey; K Moser; M Thompson; C E Davis
Journal:  Medicine (Baltimore)       Date:  1993-01       Impact factor: 1.889

10.  Zoonotic tuberculosis (Mycobacterium bovis): memorandum from a WHO meeting (with the participation of FAO).

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

View more
  13 in total

1.  The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages.

Authors:  J J De Voss; K Rutter; B G Schroeder; H Su; Y Zhu; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses.

Authors:  Lawrence D Horwitz; Marcus A Horwitz
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

3.  Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.

Authors:  Ana M Aguirre-Blanco; Pauline T Lukey; Jacqueline M Cliff; Hazel M Dockrell
Journal:  Infect Immun       Date:  2007-03-26       Impact factor: 3.441

Review 4.  Iron Homeostasis in Mycobacterium tuberculosis: Mechanistic Insights into Siderophore-Mediated Iron Uptake.

Authors:  Manjula Sritharan
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

Review 5.  The TB Structural Genomics Consortium: a decade of progress.

Authors:  Nicholas Chim; Jeff E Habel; Jodie M Johnston; Inna Krieger; Linda Miallau; Ramasamy Sankaranarayanan; Robert P Morse; John Bruning; Stephanie Swanson; Haelee Kim; Chang-Yub Kim; Hongye Li; Esther M Bulloch; Richard J Payne; Alexandra Manos-Turvey; Li-Wei Hung; Edward N Baker; J Shaun Lott; Michael N G James; Thomas C Terwilliger; David S Eisenberg; James C Sacchettini; Celia W Goulding
Journal:  Tuberculosis (Edinb)       Date:  2011-01-17       Impact factor: 3.131

Review 6.  The Iron Response of Mycobacterium tuberculosis and Its Implications for Tuberculosis Pathogenesis and Novel Therapeutics.

Authors:  G Marcela Rodriguez; Nishant Sharma; Ashis Biswas; Nevadita Sharma
Journal:  Front Cell Infect Microbiol       Date:  2022-05-11       Impact factor: 6.073

Review 7.  Understanding the Potential and Risk of Bacterial Siderophores in Cancer.

Authors:  Valentina Pita-Grisanti; Kaylin Chasser; Trevor Sobol; Zobeida Cruz-Monserrate
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

8.  Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages.

Authors:  Erin E Johnson; Chittur V Srikanth; Andreas Sandgren; Lynne Harrington; Estela Trebicka; Lijian Wang; Niels Borregaard; Megan Murray; Bobby J Cherayil
Journal:  FEMS Immunol Med Microbiol       Date:  2009-10-07

9.  Participation of fad and mbt genes in synthesis of mycobactin in Mycobacterium smegmatis.

Authors:  B Babbette D LaMarca; Wenming Zhu; Jean E L Arceneaux; B Rowe Byers; Michael D Lundrigan
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

10.  A second-generation anti TB vaccine is long overdue.

Authors:  Mauricio Castañón-Arreola; Yolanda López-Vidal
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-06-03       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.